论文部分内容阅读
胆囊癌发病率逐年增加,许多胆囊癌患者诊断的时候已经处于晚期,特别是广泛转移的患者,已经丧失了手术机会,只能姑息治疗。探讨新的、有效的治疗方法,发现有效的治疗药物,具有积极的临床意义。本研究采用免疫组织化学技术观察了表皮生长因子受体(epidermal growth factor receptor,EGFR)及人类表皮生长因子受体2(human epidermal growth factor receptor-2,HER2)在胆囊癌中的表达,以探讨胆囊癌分子靶向治疗的可能性。
The incidence of gallbladder cancer increased year by year, many patients with gallbladder cancer diagnosis is already in late, especially in patients with extensive metastasis, has lost the chance of surgery, only palliative care. To explore new and effective treatments, and to find effective therapies have positive clinical implications. In this study, immunohistochemistry was used to observe the expression of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor-2 (HER2) in gallbladder carcinomas Potential of molecular targeted therapy for gallbladder cancer.